Tag: Oral diabetes medication

Metformin is one of the most commonly prescribed medications worldwide, used primarily to treat type 2 diabetes. When you take metformin 500 mg, you initiate a process that helps control your blood glucose levels, but it can also cause some common gastrointestinal side effects, especially as your body adjusts.

According to a FAIR Health report from May 2025, over 2% of US adults took a GLP-1 medication for weight loss in 2024, reflecting the high demand for these drugs. For those who prefer tablets over injections, understanding if there is a pill alternative to Mounjaro is a crucial step in exploring treatment paths for type 2 diabetes and weight management.

According to Canadian drug records, Riva-Metformin was first approved for use on November 16, 1998, serving as a generic alternative for managing type 2 diabetes. This medication contains the active ingredient metformin hydrochloride and is manufactured by Laboratoire Riva Inc., providing a more affordable option for patients.

Alogliptin is a prescription medication primarily used alongside diet and exercise to lower high blood sugar levels in adults with type 2 diabetes. So, what is alogliptin used to treat? Its main therapeutic purpose is to improve glycemic control by helping the body manage insulin and glucose production.

According to the Centers for Disease Control and Prevention, over 38 million Americans have diabetes, with most cases being type 2 diabetes managed by medication. If you're wondering what is a blue pill for diabetes?, it's important to know that multiple medications can fit this description, and relying on color alone is extremely dangerous. A definitive identification requires examining the pill's unique imprint code and shape, not just its color.

In 2024, over 26% of adults with diagnosed diabetes used a GLP-1 injectable medication. Rybelsus (semaglutide) offers a unique alternative as the first oral tablet in this class, used with diet and exercise to improve blood sugar in adults with type 2 diabetes.